Skip to content
  • Home
  • About Us
  • Longevity Platform
  • Bio101
    • BIO101 in Sarcopenia
    • BIO101 in Obesity
  • Biophytis Biopharmaceutical
  • Other Projects
  • Resources
    • Posters & Publications
    • Scientific Press Releases
  • Recruitment
  • Investors
    • Stock Information
    • Corporate Presentation
    • Letter to shareholders
    • Press Releases
    • General Meetings
    • AMF Regulated Information
    • SEC Filings
    • Convertible bonds
    • Pre-financed vouchers (PFW)
    • Obligations Hexagon
    • Obligations Hexagon
    • Contact for Investors
  • Contact

    TNC FlipBook Classic items

    Assemblée générale mixte du 02 avril 2024

    By adminMarch 18, 2024

    240315_Biophytis_PR_Reverse_split

    By adminMarch 16, 2024

    240315_Biophytis_CP_Regroupement_d_actions

    By adminMarch 16, 2024

    240312_PR_Conferences_EN

    By adminMarch 11, 2024

    240312_CP_Conferences_FR

    By adminMarch 11, 2024

    240308_CP_Positionnement_sur_la_DMD_FR

    By adminMarch 8, 2024

    240308_PR_DMD_positioning_EN

    By adminMarch 8, 2024

    240222_PR_Biophytis_book

    By adminFebruary 22, 2024

    240222_CP_Livre_Biophytis

    By adminFebruary 22, 2024

    240104_CP_Publication_COVA_dans_EBI

    By adminJanuary 4, 2024
    ←1
    234567891011121314151617181920212223242526272829
    …3031323334→
    X
    Addresses
    Addresses

    BIOPHYTIS France
    Silver Innov’
    54 rue Molière
    94200 Ivry-Sur-Seine
    FRANCE

    Addresses

    BIOPHYTIS USA
    c/o NGIN
    210 Broadway, Suite #201
    Cambridge, MA 02139
    USA

    Addresses

    BIOPHYTIS Brazil
    CIETEC
    Av. Prof. Lineu Prestes
    2242 Cidade Universitária USP
    05508-000 São Paulo
    BRASIL

    Contact
    contact@biophytis.com +33 1 76 28 40 83
    Investors

    investors@biophytis.com

    © Biophytis 2025.

    All Rights Reserved.

    Legal information
    Webdesign by Ex Calibra
    Go to Top
    • Home
    • About Us
    • Longevity Platform
    • Bio101
      • BIO101 in Sarcopenia
      • BIO101 in Obesity
    • Biophytis Biopharmaceutical
    • Other Projects
    • Resources
      • Posters & Publications
      • Scientific Press Releases
    • Recruitment
    • Investors
      • Stock Information
      • Corporate Presentation
      • Letter to shareholders
      • Press Releases
      • General Meetings
      • AMF Regulated Information
      • SEC Filings
      • Convertible bonds
      • Pre-financed vouchers (PFW)
      • Obligations Hexagon
      • Obligations Hexagon
      • Contact for Investors
    • Contact